Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > GOLDMAN SACKS PRICE TARGET $32.00 US
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(122)
•••
Comment by fdfd12on Jun 07, 2016 8:45pm
146 Views
Post# 24944262

RE:RE:RE:GOLDMAN SACKS PRICE TARGET $32.00 US

RE:RE:RE:GOLDMAN SACKS PRICE TARGET $32.00 US

Concordia Healthcare " NEUTRAL"

Analysts at Goldman Sachs initiated coverage of Concordia Healthcare with a "NEUTRAL" rating on Tuesday and a 12-month target price of $42.00
Company Ticker Rating Previous Rating Target Price Previous Target Price Analyst Date
North West Company Inc NWC    $29.00 $28.00 Barclays Capital 07 Jun 2016
Emera Inc EMA OVERWEIGHT EQUAL-WEIGHT  $52.00 $50.00 Barclays Capital 07 Jun 2016
Altagas ALA SECTOR PERFORM    $34.00   CIBC World Markets 07 Jun 2016
Centerra Gold Inc CG MARKET PERFORM BUY   Cormark Securities 07 Jun 2016
Concordia Healthcare CXR NEUTRAL    $42.00   Goldman Sachs 07 Jun 2016






YourMindIz wrote: fdfd
Its $32US; someone is trying to be creative by converting and upping the number

$32 US = $40..81 CDN

Just keep the quote like the analyst stated $32US  (even tho we know its for CXRX so obviously US


fdfd12 wrote: I got it this morning.
GS starts from neutral with $42CAN!!!

YourMindIz wrote: Someone here posted an incorrect price target for Goldman earlier and Roller also had the wrong conversion to Canadian dollars. 

The Correct Price Target is $32.00 US   

 




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities